Viewing StudyNCT03666988



Ignite Creation Date: 2024-05-06 @ 12:03 PM
Last Modification Date: 2024-10-26 @ 12:53 PM
Study NCT ID: NCT03666988
Status: TERMINATED
Last Update Posted: 2022-05-20
First Post: 2018-09-10

Brief Title: First Time in Humans FTIH Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma DLBCL
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-10-22
Start Date Type: ACTUAL
Primary Completion Date: 2021-03-04
Primary Completion Date Type: ACTUAL
Completion Date: 2021-03-04
Completion Date Type: ACTUAL
First Submit Date: 2018-09-10
First Submit QC Date: September 10 2018
Study First Post Date: 2018-09-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2022-05-20
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-03-01
Last Update Post Date: 2022-05-20
Last Update Post Date Type: ACTUAL